Literature DB >> 17567693

Identification of a novel virulence factor in recombinant pneumonia virus of mice.

Christine D Krempl1, Anna Wnekowicz, Elaine W Lamirande, Giw Nayebagha, Peter L Collins, Ursula J Buchholz.   

Abstract

Pneumonia virus of mice (PVM) is a murine relative of human respiratory syncytial virus (HRSV). Here we developed a reverse genetics system for PVM based on a consensus sequence for virulent strain 15. Recombinant PVM and a version engineered to express green fluorescent protein replicated as efficiently as the biological parent in vitro but were 4- and 12.5-fold attenuated in vivo, respectively. The G proteins of HRSV and PVM have been suggested to contribute to viral pathogenesis, but this had not been possible to study in a defined manner in a fully permissive host. As a first step, we evaluated recombinant mutants bearing a deletion of the entire G gene (Delta G) or expressing a G protein lacking its cytoplasmic tail (Gt). Both G mutants replicated as efficiently in vitro as their recombinant parent, but both were nonpathogenic in mice at doses that would otherwise be lethal. We could not detect replication of the Delta G mutant in mice, indicating that its attenuation is based on a severe reduction in the virus load. In contrast, the Gt mutant appeared to replicate as efficiently in mice as its recombinant parent. Thus, the reduction in virulence associated with the Gt mutant could not be accounted for by a reduction in viral replication. These results identified the cytoplasmic tail of G as a virulence factor whose effect is not mediated solely by the viral load. In addition to its intrinsic interest, a recombinant virus that replicates with wild-type-like efficiency but does not cause disease defines optimal properties for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567693      PMCID: PMC1951446          DOI: 10.1128/JVI.00364-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.

Authors:  Fernando P Polack; Pablo M Irusta; Scott J Hoffman; M Paula Schiatti; Guillermina A Melendi; M Florencia Delgado; Federico R Laham; Bhagvanji Thumar; R Michael Hendry; Jose A Melero; Ruth A Karron; Peter L Collins; Steven R Kleeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

2.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

3.  Genome sequence of the non-pathogenic strain 15 of pneumonia virus of mice and comparison with the genome of the pathogenic strain J3666.

Authors:  L C Thorpe; A J Easton
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

4.  Complete sequence of the RNA genome of pneumonia virus of mice (PVM).

Authors:  Christine D Krempl; Elaine W Lamirande; Peter L Collins
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

5.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes.

Authors:  Stéphane Biacchesi; Mario H Skiadopoulos; Kim C Tran; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

7.  Fatal pneumonia with terminal emaciation in nude mice caused by pneumonia virus of mice.

Authors:  C B Richter; J E Thigpen; C S Richter; J M Mackenzie
Journal:  Lab Anim Sci       Date:  1988-06

8.  Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization.

Authors:  P M Cook; R P Eglin; A J Easton
Journal:  J Gen Virol       Date:  1998-10       Impact factor: 3.891

9.  New isolates of pneumonia virus of mice (PVM) from Japanese rat colonies and their characterization.

Authors:  H Miyata; M Kishikawa; H Kondo; C Kai; Y Watanabe; K Ohsawa; H Sato
Journal:  Exp Anim       Date:  1995-04

10.  A LATENT VIRUS IN NORMAL MICE CAPABLE OF PRODUCING PNEUMONIA IN ITS NATURAL HOST.

Authors:  F L Horsfall; R G Hahn
Journal:  J Exp Med       Date:  1940-02-29       Impact factor: 14.307

View more
  16 in total

Review 1.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

2.  Evaluation of pneumonia virus of mice as a possible human pathogen.

Authors:  Linda G Brock; Ruth A Karron; Christine D Krempl; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

3.  Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.

Authors:  Linda G Brock; Xiang Liu; Bo Liang; Matthias Lingemann; Xueqiao Liu; Richard Herbert; Ashley D Hackenberg; Ursula J Buchholz; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  CD8+ T-cell epitope mapping for pneumonia virus of mice in H-2b mice.

Authors:  Kevin B Walsh; John Sidney; Megan Welch; Daniel M Fremgen; Alessandro Sette; Michael B A Oldstone
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

5.  Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

Authors:  Konrad Wilhelm; Jayanthi Ganesan; Tobias Müller; Christoph Dürr; Melanie Grimm; Andreas Beilhack; Christine D Krempl; Stephan Sorichter; Ulrike V Gerlach; Eva Jüttner; Alf Zerweck; Frank Gärtner; Patrizia Pellegatti; Francesco Di Virgilio; Davide Ferrari; Neeraja Kambham; Paul Fisch; Jürgen Finke; Marco Idzko; Robert Zeiser
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

6.  Role of T cells in virus control and disease after infection with pneumonia virus of mice.

Authors:  Stefanie Frey; Christine D Krempl; Annette Schmitt-Gräff; Stephan Ehl
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

7.  Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.

Authors:  Ursula J Buchholz; Jerrold M Ward; Elaine W Lamirande; Britta Heinze; Christine D Krempl; Peter L Collins
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

Review 8.  Pneumonia virus of mice: severe respiratory infection in a natural host.

Authors:  Helene F Rosenberg; Joseph B Domachowske
Journal:  Immunol Lett       Date:  2008-04-22       Impact factor: 3.685

9.  Novel pneumoviruses (PnVs): Evolution and inflammatory pathology.

Authors:  Stephanie F Glineur; Randall W Renshaw; Caroline M Percopo; Kimberly D Dyer; Edward J Dubovi; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2013-06-10       Impact factor: 3.616

10.  Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM).

Authors:  Kimberly D Dyer; Rebecca A Drummond; Tyler A Rice; Caroline M Percopo; Todd A Brenner; Derek A G Barisas; Kendal A Karpe; Martin L Moore; Helene F Rosenberg
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.